📋 Tender Overview
In-Situ & Operando Organic Electrochemical Transistors Monitored By Non-Destructive Spectroscopies For Organic Cmos-Like Neuromorphic Circuits
Ultra-flexible, conformable and implantable artificial intelligence organic electronic devices hold promise to revolutionize the real-time monitoring and treatment of chronic diseases. Such devices are based on organic electrochemical transistors (OECTs) exploiting polymeric mixed ion-to-electron conductors (PMIECs) as active layers. However, the development of efficient and stable devices is hindered by limited knowledge about structure-property relationships of PMIECs.
ICONIC combines macromolecular synthesis with in situ and operando non-destructive spectroscopic methods in an innovative way to investigate with unprecedented accuracy ion-to-electron transduction in OECTs, from the molecular to the micrometre scale. This provides the key knowledge to make a technological leap in development of smart therapeutic devices.
As a proof of concept, ICONIC develops an intelligent closed-loop device for drug-delivery activation. In a long-term vision, healthcare devices will enable signal recognition with body-friendly electronics and administer medication without the risk of human error.
Funded Under
The European Innovation Council (Eic)
Total Cost
€ 2 664 940,00
Eu Contribution
€ 2 664 940,00
Coordinated By
Institut Mines-Telecom
France
